Citation: | Pan Tianzhong, Tang Baolin, Zhu Xiaoyu, et al. Effect of pretransplant iron overload on clinical efficacy of allogeneic hematopoietic stem cell transplantation on severe aplastic anemia[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 234-239. doi: 10.3969/j.issn.1674-7445.2020.02.008 |
[1] |
GEORGES GE, DONEY K, STORB R. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment[J]. Blood Adv, 2018, 2(15):2020-2028. DOI: 10.1182/bloodadvances.2018021162.
|
[2] |
PESLAK SA, OLSON T, BABUSHOK DV. Diagnosis and treatment of aplastic anemia[J]. Curr Treat Options Oncol, 2017, 18(12):70. DOI: 10.1007/s11864-017-0511-z.
|
[3] |
XU LP, WANG SQ, MA YR, et al. Who is the best haploidentical donor for acquired severe aplastic anemia? experience from a multicenter study[J]. J Hematol Oncol, 2019, 12(1):87. DOI: 10.1186/s13045-019-0775-9.
|
[4] |
LEE SE, YAHNG SA, CHO BS, et al. Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia[J]. Bone Marrow Transplant, 2016, 51(10):1323-1329. DOI: 10.1038/bmt.2016.140.
|
[5] |
KILLICK SB, BOWN N, CAVENAGH J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia[J]. Br J Haematol, 2016, 172(2):187-207. DOI: 10.1111/bjh.13853.
|
[6] |
LIU HL, SUN ZM, GENG LQ, et al. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival[J]. Bone Marrow Transplant, 2012, 47(9):1186-1190. DOI: 10.1038/bmt.2011.251.
|
[7] |
LEE JW, YOON SS, SHEN ZX, et al. Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial[J]. Blood, 2010, 116(14):2448-2454. DOI: 10.1182/blood-2010-01-261289.
|
[8] |
WOOD JC, ENRIQUEZ C, GHUGRE N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients[J]. Blood, 2005, 106(4):1460-1465. doi: 10.1182/blood-2004-10-3982
|
[9] |
MAVROGENI S, KOLOVOU G, BIGALKE B, et al. Transplantation in patients with iron overload: is there a place for magnetic resonance imaging? : transplantation in iron overload[J]. Heart Fail Rev, 2018, 23(2):173-180. DOI: 10.1007/s10741-018-9670-7.
|
[10] |
HARRIS AC, YOUNG R, DEVINE S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD international consortium[J]. Biol Blood Marrow Transplant, 2016, 22(1):4-10. DOI: 10.1016/j.bbmt.2015.09.001.
|
[11] |
黄蕾, 付蓉.铁过载影响骨髓造血特点及机制研究进展[J].中华血液学杂志, 2019, 40(8):709-712.DOI:10. 3760/cma.j.issn.0253-2727.2019.08.021.
HUANG L, FU R. Research progress of characteristics and mechanisms of iron overload affecting bone marrow hematopoiesis[J]. Chin J Hema, 2019, 40(8):709-712. DOI: 10.3760/cma.j.issn.0253-2727.2019.08.021.
|
[12] |
MCELDUFF A. Iron: how much is too much?[J]. Diabetologia, 2017, 60(2):237-239. DOI: 10.1007/s00125-016-4176-0.
|
[13] |
GUPTA R, MUSALLAM KM, TAHER AT, et al. Ineffective erythropoiesis: anemia and iron overload[J]. Hematol Oncol Clin North Am, 2018, 32(2):213-221. DOI: 10.1016/j.hoc.2017.11.009.
|
[14] |
TAKAMI A. Hematopoietic stem cell transplantation for acute myeloid leukemia[J]. Int J Hematol, 2018, 107(5):513-518. DOI: 10.1007/s12185-018-2412-8.
|
[15] |
FARACI M, BAGNASCO F, LEONI M, et al. Evaluation of chimerism dynamics after allogeneic hematopoietic stem cell transplantation in children with nonmalignant diseases[J]. Biol Blood Marrow Transplant, 2018, 24(5):1088-1093. DOI: 10.1016/j.bbmt.2017.12.801.
|
[16] |
MAXIMOVA N, GREGORI M, SIMEONE R, et al. Total body irradiation and iron chelation treatment are associated with pancreatic injury following pediatric hematopoietic stem cell transplantation[J]. Oncotarget, 2018, 9(28): 19543-19554. DOI: 10.18632/oncotarget.24646.
|
[17] |
ALVA LC, BACHER U, SEIPEL K, et al. Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia[J]. Transfusion, 2018, 58(10):2365-2373. DOI: 10.1111/trf.14895.
|
[18] |
ZHANG X, SHI Y, HUANG Y, et al. Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia[J]. Hematology, 2018, 23(5):291-298. DOI: 10.1080/10245332.2017.1390929.
|
[19] |
WERMKE M, ECKOLDT J, GÖTZE KS, et al. Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial[J]. Lancet Haematol, 2018, 5(5):e201-e210. DOI: 10.1016/S2352-3026(18)30036-X.
|
[20] |
KONG Y, SONG Y, HU Y, et al. Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants[J]. Oncotarget, 2016, 7(21):30892-30906. DOI: 10.18632/oncotarget.8810.
|
[21] |
MAXIMOVA N, GREGORI M, BOZ G, et al. MRI-based evaluation of multiorgan iron overload is a predictor of adverse outcomes in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation[J]. Oncotarget, 2017, 8(45):79650-79661. DOI: 10.18632/oncotarget.19021.
|
[22] |
SAKAMOTO S, KAWABATA H, KANDA J, et al. High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation[J]. Cancer Med, 2017, 6(1):120-128. DOI: 10.1002/cam4.974.
|
[23] |
PULLARKAT V, BLANCHARD S, TEGTMEIER B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation[J]. Bone Marrow Transplant, 2008, 42(12):799-805. DOI: 10.1038/bmt. 2008.262.
|
[24] |
SIVGIN S, BALDANE S, KAYNAR L, et al. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation[J]. Neoplasma, 2012, 59(2):183-190. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=fb85e90cb716a13a6b3b98c434928cf5
|
[25] |
LEITCH HA, FIBACH E, RACHMILEWITZ E. Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies[J]. Crit Rev Oncol Hematol, 2017, 113:156-170. DOI: 10.1016/j.critrevonc.2017.03.002.
|
[26] |
OHMOTO A, FUJI S, MIYAGI-MAESHIMA A, et al. Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection[J]. Bone Marrow Transplant, 2017, 52(8):1201-1203. DOI: 10.1038/bmt.2017.93.
|